DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2021

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2021
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2021
The figures have not been audited

Attachments

DBB Bursa Report Q4 2021.pdf
323.9 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2021

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2021
31 Dec 2020
31 Dec 2021
31 Dec 2020
$$'000
$$'000
$$'000
$$'000
1 Revenue
145,444
134,086
639,175
569,902
2 Profit/(loss) before tax
17,128
20,471
82,983
76,157
3 Profit/(loss) for the period
15,716
16,193
65,683
58,610
4 Profit/(loss) attributable to ordinary equity holders of the parent
15,716
16,193
65,683
58,610
5 Basic earnings/(loss) per share (Subunit)
1.67
1.72
6.98
6.31
6 Proposed/Declared dividend per share (Subunit)
1.80
6.00
2.30
6.50


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.6600
0.6800

Remarks : 
(1) Pursuant to MFRS 133 Earnings Per Share, the Earnings Per Share for the corresponding quarter and year to date ended 31 December 2020 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021.

(2) For comparative purposes, the Net Assets per share for the corresponding year to date ended 31 December 2020 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 15 Feb 2022
Category Financial Results
Reference Number FRA-04022022-00001


View original report